Compton Wealth Advisory Group LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,405 shares of the healthcare conglomerate’s stock after selling 59 shares during the quarter. Compton Wealth Advisory Group LLC’s holdings in UnitedHealth Group were worth $2,622,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. Bayforest Capital Ltd increased its position in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd increased its position in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares during the last quarter. Copia Wealth Management purchased a new stake in UnitedHealth Group in the fourth quarter worth $42,000. IAG Wealth Partners LLC purchased a new stake in UnitedHealth Group in the first quarter worth $42,000. Finally, Investment Management Corp VA ADV purchased a new stake in UnitedHealth Group in the fourth quarter worth $44,000. 87.86% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several brokerages have recently weighed in on UNH. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. JPMorgan Chase & Co. reduced their price target on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research report on Wednesday, August 6th. Morgan Stanley lifted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Wells Fargo & Company reduced their price target on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Finally, Oppenheimer reduced their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.
UnitedHealth Group Trading Up 0.5%
Shares of UNH stock opened at $341.46 on Thursday. The stock has a market capitalization of $309.25 billion, a PE ratio of 14.79, a P/E/G ratio of 2.22 and a beta of 0.45. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The business has a 50-day moving average of $294.30 and a 200 day moving average of $367.06. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Stock Market Upgrades: What Are They?
- Biotech Breakouts: 3 Stocks With Massive Upside Potential
- 3 Best Fintech Stocks for a Portfolio Boost
- Powering Up: A Buy Rating Signals GE Vernova’s AI Tailwinds
- What is MarketRank� How to Use it
- The Side of Rate Cuts Nobody Is Telling You About
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.